ESR1 and neoplasm: Furthermore, combining pan-SRC SMI and oral SERD treatments have a synergistic effect on both LBD mutant transcriptional activity and cell growth (Fig. 2), and, more importantly, Y537S ERα-expressing PDX tumor growth (Fig. 3).